Impact of intravitreal injection therapy on contrast sensitivity in patients with nAMD and DME.

Authors:
Dieke S; Wurche S; Ruebsam A; Wirbelauer C; Joussen AM and 1 more

Journal:
Graefes Arch Clin Exp Ophthalmol

Publication Year: 2023

DOI:
10.1007/s00417-022-05944-8

PMCID:
PMC10272247

PMID:
36622409

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Graefes Arch Clin Exp Ophthalmol

Abbreviation: Graefes Arch Clin Exp Ophthalmol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A case study in applying artificial intelligence-based named entity recognition to develop an autom…
Macri CZ; Teoh SC; Bacchi S and 5 more (2023) - Transparency Score: 3/6
Accelerated corneal cross-linking (18mW/cm2 for 5 min) with HPMC-riboflavin in progressive keratoco…
Friedrich J; Sandner A; Nasseri A and 2 more (2023) - Transparency Score: 3/6
A mini-invasive surgical technique for Carlevale IOL implantation: case series study and descriptio…
Danese C; Di Bin F; Lanzetta P. (2023) - Transparency Score: 3/6
A novel quick contrast sensitivity function test in Chinese adults with myopia and its related para…
Ye Y; Aruma A; Zhao W and 3 more (2023) - Transparency Score: 3/6
A rabbit model for outer retinal atrophy caused by surgical RPE removal.
Al-Nawaiseh S; Krötz C; Rickmann A and 6 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approvalThis study adhered to the ethical standards of the Declaration of Helsinki. Institutional ethical approval was obtained by the Ethics Committee of the Charité-Universitätsmedizin Berlin (EA4/072/22). Consent to participateAll participants provided their written informed consent. Conflict of interestThe authors declare no competing interests. Conflict of interest The authors declare no competing interests."

Evidence found in paper:

"Funding Open Access funding enabled and organized by Projekt DEAL."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025